ClinVar Miner

Submissions for variant NM_001005361.3(DNM2):c.868C>T (p.Arg290Trp)

gnomAD frequency: 0.00005  dbSNP: rs587778235
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000766941 SCV000532701 uncertain significance not provided 2016-11-01 criteria provided, single submitter clinical testing A variant of uncertain significance has been identified in the DNM2 gene. The R290W variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The R290W variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The R290W variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant.
Labcorp Genetics (formerly Invitae), Labcorp RCV000821354 SCV000962108 uncertain significance Charcot-Marie-Tooth disease dominant intermediate B 2024-11-19 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 290 of the DNM2 protein (p.Arg290Trp). This variant is present in population databases (rs587778235, gnomAD 0.004%). This missense change has been observed in individual(s) with distal hereditary neuropathy (PMID: 33369814). ClinVar contains an entry for this variant (Variation ID: 133980). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on DNM2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV002371955 SCV002684487 uncertain significance Inborn genetic diseases 2021-11-02 criteria provided, single submitter clinical testing The p.R290W variant (also known as c.868C>T), located in coding exon 7 of the DNM2 gene, results from a C to T substitution at nucleotide position 868. The arginine at codon 290 is replaced by tryptophan, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Revvity Omics, Revvity RCV000766941 SCV003830491 uncertain significance not provided 2019-03-21 criteria provided, single submitter clinical testing
ITMI RCV000120649 SCV000084810 not provided not specified 2013-09-19 no assertion provided reference population

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.